FDA | Press Releases
Follow
FDA Takes Further Steps to Streamline Biosimilar Development and Make Medicines More Affordable
The U.S. Food and Drug Administration today announced another major step in its initiative to streamline the development of biosimilar medicines, which are like “generic” versions of biologic drugs.
